"Oct. 18, 2012 -- While the use of long-acting intrauterine devices (IUDs) is increasing, 1 in 9 women at risk for unintended pregnancies is not using any birth control, according to a new government report.
Researchers from the Natio"...
Overdosage of estrogen plus progestin therapy may cause nausea and vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue and withdrawal bleeding may occur in women. Treatment of overdose consists of discontinuation of CE/MPA together with institution of appropriate symptomatic care.
PROVERA (medroxyprogesterone acetate tablets) should not be used in women with any of the following conditions:
- Undiagnosed abnormal genital bleeding
- Known, suspected, or history of cancer of the breast
- Known or suspected estrogen- or progesterone-dependent neoplasia
- Active deep vein thrombosis, pulmonary embolism or a history of these conditions
- Active or recent (within the past year) arterial thromboembolic disease (for example, stroke and myocardial infarction)
- Known liver dysfunction or disease
- Missed abortion
- As a diagnostic test for pregnancy
- Known hypersensitivity to the ingredients in PROVERA (medroxyprogesterone acetate tablets) tablets
- Known or suspected pregnancy.
Last reviewed on RxList: 4/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Provera Information
Provera - User Reviews
Provera User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.